Paper34604239
miR-29b-3p Increases Radiosensitivity in Stemness Cancer Cells via Modulating Oncogenes Axis.
Pan D and 6 others. Front Cell Dev Biol, 2021. Cited by 16 papers, by iCite.
Cite this record
ConductScience Library. miR-29b-3p Increases Radiosensitivity in Stemness Cancer Cells via Modulating Oncogenes Axis. Papers, record 34604239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34604239
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- miR-29b-3p Increases Radiosensitivity in Stemness Cancer Cells via Modulating Oncogenes Axis.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References64
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22214600 | The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury. | Physiol Genomics | 2012 | https://conductscience.org/library/papers/22214600 | PubMed |
| 2 | 17524393 | Cell shape regulates global histone acetylation in human mammary epithelial cells. | Exp Cell Res | 2007 | https://conductscience.org/library/papers/17524393 | PubMed |
| 3 | 25767398 | The role of miR-29b in cancer: regulation, function, and signaling. | Onco Targets Ther | 2015 | https://conductscience.org/library/papers/25767398 | PubMed |
| 4 | 11316541 | Apoptosis and bcl-2 expression as predictors of survival in radiation-treated non-small-cell lung cancer. | Int J Radiat Oncol Biol Phys | 2001 | https://conductscience.org/library/papers/11316541 | PubMed |
| 5 | 24909176 | c-Myc suppresses microRNA-29b to promote tumor aggressiveness and poor outcomes in non-small cell lung cancer by targeting FHIT. | Oncogene | 2015 | https://conductscience.org/library/papers/24909176 | PubMed |
| 6 | 26716904 | Cancer stem cells and signaling pathways in radioresistance. | Oncotarget | 2016 | https://conductscience.org/library/papers/26716904 | PubMed |
| 7 | 24872697 | Enhancement of radiotherapy efficacy by miR-200c-loaded gelatinase-stimuli PEG-Pep-PCL nanoparticles in gastric cancer cells. | Int J Nanomedicine | 2014 | https://conductscience.org/library/papers/24872697 | PubMed |
| 8 | 17185610 | Side population analysis using a violet-excited cell-permeable DNA binding dye. | Stem Cells | 2007 | https://conductscience.org/library/papers/17185610 | PubMed |
| 9 | 26984757 | An Epigenetic Reprogramming Strategy to Resensitize Radioresistant Prostate Cancer Cells. | Cancer Res | 2016 | https://conductscience.org/library/papers/26984757 | PubMed |
| 10 | 24091622 | Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin-integrin signalling in head and neck squamous cell carcinoma. | Br J Cancer | 2013 | https://conductscience.org/library/papers/24091622 | PubMed |
| 11 | 30944638 | c-Myc maintains the self-renewal and chemoresistance properties of colon cancer stem cells. | Oncol Lett | 2019 | https://conductscience.org/library/papers/30944638 | PubMed |
| 12 | 26175931 | PI3K/Akt/mTOR signaling pathway in cancer stem cells: from basic research to clinical application. | Am J Cancer Res | 2015 | https://conductscience.org/library/papers/26175931 | PubMed |
| 13 | 20442295 | Three-dimensional cell growth confers radioresistance by chromatin density modification. | Cancer Res | 2010 | https://conductscience.org/library/papers/20442295 | PubMed |
| 14 | 24206455 | microRNAs in cancer cell response to ionizing radiation. | Antioxid Redox Signal | 2014 | https://conductscience.org/library/papers/24206455 | PubMed |
| 15 | 19079265 | miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42. | Nat Struct Mol Biol | 2009 | https://conductscience.org/library/papers/19079265 | PubMed |
| 16 | 21951844 | Overexpression of microRNA-29b induces apoptosis of multiple myeloma cells through down regulating Mcl-1. | Biochem Biophys Res Commun | 2011 | https://conductscience.org/library/papers/21951844 | PubMed |
| 17 | 25568669 | The Bcl-2 inhibitor Obatoclax overcomes resistance to histone deacetylase inhibitors SAHA and LBH589 as radiosensitizers in patient-derived glioblastoma stem-like cells. | Genes Cancer | 2014 | https://conductscience.org/library/papers/25568669 | PubMed |
| 18 | 27527863 | Radiation induces premature chromatid separation via the miR-142-3p/Bod1 pathway in carcinoma cells. | Oncotarget | 2016 | https://conductscience.org/library/papers/27527863 | PubMed |
| 19 | 17179479 | The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. | J Natl Cancer Inst | 2006 | https://conductscience.org/library/papers/17179479 | PubMed |
| 20 | 20041405 | Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. | Hepatology | 2010 | https://conductscience.org/library/papers/20041405 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41606241 | Loss of MicroRNA-29b promotes DNMT3b-mediated STING downregulation to attenuate radiotherapy-induced antitumor immunity in KRAS-mutated colorectal cancer. | NPJ Precis Oncol | 2026 | https://conductscience.org/library/papers/41606241 | PubMed |
| 41493679 | The epigenetic regulator SETDB1 as a key component of cancer stem cells and drug resistance in primary liver cancer. | Cell Oncol (Dordr) | 2026 | https://conductscience.org/library/papers/41493679 | PubMed |
| 41400771 | High TRA2B expression mediated by ncRNA correlates with adverse outcomes and tumor immune infiltration in hepatocellular carcinoma. | Discov Oncol | 2025 | https://conductscience.org/library/papers/41400771 | PubMed |
| 41375031 | Epigenetic and Transcriptional Reprogramming in 3D Culture Models in Breast Cancer. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41375031 | PubMed |
| 40710326 | Regulatory Functions of microRNAs in Cancer Stem Cells: Mechanism, Facts, and Perspectives. | Cells | 2025 | https://conductscience.org/library/papers/40710326 | PubMed |
| 39917986 | Unleashing the power of urine‑based biomarkers in diagnosis, prognosis and monitoring of bladder cancer (Review). | Int J Oncol | 2025 | https://conductscience.org/library/papers/39917986 | PubMed |
| 39545960 | Non-coding RNAs modulation in breast cancer radioresponse: mechanisms and therapeutic implications. | Strahlenther Onkol | 2025 | https://conductscience.org/library/papers/39545960 | PubMed |
| 37958993 | Unraveling the Potential of miRNAs from CSCs as an Emerging Clinical Tool for Breast Cancer Diagnosis and Prognosis. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37958993 | PubMed |
| 37569824 | Connection between Radiation-Regulating Functions of Natural Products and miRNAs Targeting Radiomodulation and Exosome Biogenesis. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37569824 | PubMed |
| 37416747 | Identification of hub genes and microRNAs with prognostic values in esophageal cancer by integrated analysis. | Noncoding RNA Res | 2023 | https://conductscience.org/library/papers/37416747 | PubMed |
| 37373065 | In Silico Identification of a BRCA1:miR-29:DNMT3 Axis Involved in the Control of Hormone Receptors in BRCA1-Associated Breast Cancers. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37373065 | PubMed |
| 36902482 | Discovering the Biological Significance and Therapeutic Potential of miR-29b-3p in Triple-Negative Breast Cancer. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36902482 | PubMed |
| 36140539 | Mir-29b in Breast Cancer: A Promising Target for Therapeutic Approaches. | Diagnostics (Basel) | 2022 | https://conductscience.org/library/papers/36140539 | PubMed |
| 35743776 | Vav1 Selectively Down-Regulates Akt2 through miR-29b in Certain Breast Tumors with Triple Negative Phenotype. | J Pers Med | 2022 | https://conductscience.org/library/papers/35743776 | PubMed |
| 35628157 | Cellular and Molecular Profiling of Tumor Microenvironment and Early-Stage Lung Cancer. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35628157 | PubMed |
Genes17
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34604239
GET https://conductscience.org/api/papers/v1/34604239/references?page=2